<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
Sign Up
    December 3, 2022

    Recorded Webinar: Computation in Drug Discovery — An Insider’s View

    CDD Webinar Recorded Live Logo

    Webinar: Computation in Drug Discovery - An Insider's View

    Recorded live December 1, 2022

    Computational and data-driven drug discovery approaches are promising to revolutionize the biopharmaceutical industry. On a practical level, however, research teams need to overcome a number of challenges to truly harness the power of data and turn it into discoveries.

    In this webinar, we've invited two industry veterans, Drs. Josh Horan (Nuvalent) and Michael Kappler (IDEAYA Biosciences), to share their first-hand experience working with data at leading biotech companies. We will go beyond the hype of AI/machine learning and dive into the nuts and bolts of building computational drug discovery capabilities from the ground up.


    Download Slides (PDF)


    Speaker includes...


    Eric Gifford, PhD

    Customer Success Scientist, CDD

    Eric Gifford is a Customer Success Scientist at Collaborative Drug Discovery. Prior to joining CDD, he had a long tenure with multinational pharmaceutical companies Merck and Pfizer where he lead many informatics projects.

    Dr. Gifford received a Bachelor of Science degree from The University of Akron, a Master of Science degree from Kent State University and a PhD in Chemistry from the University of Toledo.


    Joshua Horan, PhD

    VP Medicinal Chemistry, Nuvalent

    Joshua Horan is the Vice President of Medicinal Chemistry at Nuvalent Inc, a biotech company creating precisely targeted therapies for patients with cancer. Previously Dr. Horan worked at Proteostasis Therapeutics, working in phenotypic drug discovery. He started his career at Boehringer Ingelheim working on small molecule drug discovery in inflammation and immunology.

    Dr. Horan received a Bachelor of Science degree from Carnegie Melon University and a PhD in organic chemistry from Stanford University.


    Michael Kappler, PhD

    Head of Research Infomatics, IDEAYA Biosciences

    Michael Kappler joined IDEAYA Biosciences, a synthetic lethality-focused precision medicine oncology company, in 2020 to lead its Research Informatics team. Prior to joining IDEAYA, he worked at Nurix, Roche, Amgen, Daylight, and founded Moonlight Informatics & Computing Knowledge LLC.

    Dr. Kappler has a Bachelor's degree from Eastern Michigan University and a PhD in chemistry from University of California, Santa Cru

    Tag(s): CDD Blog , Webinars

    Other posts you might be interested in

    View All Posts
    CDD Blog
    8 min   June 13, 2024
    Drug Discovery Industry Roundup with Barry Bunin — June, 13 2024
    Read More
    CDD Vault Updates
    4 min   June 10, 2024
    CDD Vault Update (June 2024): Add a Title, Arbitrary Lines, Add/Remove Whiskers in Dose-response Plots, Request More Bioisostere Hits, and Indent Lists in ELN
    Read More
    CDD Vault Updates
    3 min   May 24, 2024
    CDD Vault Update (May 2024 #3): Resume Vault Session & Deep Learning Enhancements: More Hits, Persist Calculated Properties
    Read More